多祖先的外体研究确定了与阿尔茨海默病保护相关的变体
Zainab Khurshid1,2, John J Farrell2, Tong Tong1,2
1Bioinformatics Program, Boston University, Boston, MA, USA.
Journal of Alzheimer's disease : JAD
|December 22, 2025
概括
这项研究在不同人群中确定了与阿尔茨海默病 (AD) 风险相关的新鲜罕见变异. 在BTBD8和LINGO1等基因的发现为AD病变发生提供了新的见解.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 人口健康 人口健康
背景情况:
- 之前的全基因组研究发现了罕见变体与晚发性阿尔茨海默病 (AD) 之间的关联,但需要更大的样本大小.
- 这项研究解决了对跨越不同祖先群体的AD遗传基础进行扩大研究的需求.
研究的目的:
- 为了确定罕见编码变体和阿尔茨海默病 (AD) 风险之间的关联.
- 分析一个大规模的,多祖先的外体数据集,以寻找与AD的新型遗传关联.
主要方法:
- 结合了来自阿尔茨海默氏病测序项目 (ADSP) 的全外体和全基因组测序数据.
- 分析了34202个人 (≥60岁) 在欧洲,非洲裔美国人,加勒比海西班牙裔和美洲原住民西班牙裔人口中的样本.
- 用GENESIS进行变异关联测试,用SAIGE对预测中等和高影响变异进行基因测试.
主要成果:
- 鉴定了全新的全研究显著关联 (p <1.97×10−7) 与BTBD8,LINGO1和KCNG2.2的变异.
- 在所有分析的种群中确认了与APOE的显著关联.
- 在加勒比海西班牙裔个体中检测到与PSEN1误解突变G206A.的显著关联.
结论:
- 在以前未被识别的基因中发现了与阿尔茨海默病风险相关的罕见变异.
- 这些发现有助于对阿尔茨海默氏症复杂的病变产生新的见解.
- 这项研究强调了多祖先分析在揭示AD遗传结构方面的重要性.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.5K
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.5K
相关概念视频
01:11Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:05Single Nucleotide Polymorphisms-SNPs
17.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K